Correlation Between Genovate Biotechnology and Ma Kuang

Can any of the company-specific risk be diversified away by investing in both Genovate Biotechnology and Ma Kuang at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genovate Biotechnology and Ma Kuang into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Genovate Biotechnology Co and Ma Kuang Healthcare, you can compare the effects of market volatilities on Genovate Biotechnology and Ma Kuang and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genovate Biotechnology with a short position of Ma Kuang. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genovate Biotechnology and Ma Kuang.

Diversification Opportunities for Genovate Biotechnology and Ma Kuang

-0.5

Correlation Coefficient

Genovate Biotechnology  Ma Kuang

Very good diversification

The 3 months correlation between Genovate and 4139 is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Genovate Biotechnology Co and Ma Kuang Healthcare in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ma Kuang Healthcare and Genovate Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genovate Biotechnology Co are associated (or correlated) with Ma Kuang. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ma Kuang Healthcare has no effect on the direction of Genovate Biotechnology i.e., Genovate Biotechnology and Ma Kuang go up and down completely randomly.

Pair Corralation between Genovate Biotechnology and Ma Kuang

Assuming the 90 days trading horizon Genovate Biotechnology Co is expected to generate 1.45 times more return on investment than Ma Kuang. However, Genovate Biotechnology is 1.45 times more volatile than Ma Kuang Healthcare. It trades about 0.1 of its potential returns per unit of risk. Ma Kuang Healthcare is currently generating about -0.06 per unit of risk. If you would invest  2,070  in Genovate Biotechnology Co on December 23, 2024 and sell it today you would earn a total of  245.00  from holding Genovate Biotechnology Co or generate 11.84% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Genovate Biotechnology Co  vs.  Ma Kuang Healthcare

Genovate Biotechnology

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Genovate Biotechnology Co are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Genovate Biotechnology showed solid returns over the last few months and may actually be approaching a breakup point.

Ma Kuang Healthcare

Risk-Adjusted Performance

Very Weak

Over the last 90 days Ma Kuang Healthcare has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Ma Kuang is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Genovate Biotechnology and Ma Kuang

The main advantage of trading using opposite Genovate Biotechnology and Ma Kuang positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genovate Biotechnology position performs unexpectedly, Ma Kuang can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ma Kuang will offset losses from the drop in Ma Kuang's long position.

The idea behind Genovate Biotechnology Co and Ma Kuang Healthcare pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.